Clinical Trial Update: Multicentre Registry of Treatments and Outcomes in Patients With Chronic Lymphocytic Leukaemia (CLL) Or Indolent Non Hodgkin's Lymphoma (iNHL)

View source ↗

Summary

A multicenter registry examining treatments and outcomes for patients with chronic lymphocytic leukemia and indolent non-Hodgkin lymphoma has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia
• Indolent Non-hodgkin Lymphoma

Snippet

Sponsor: Astellas Pharma International B.V. | Conditions: Indolent Non Hodgkin's Lymphoma (iNHL), Chronic Lymphocytic Leukaemia (CLL) | Status: TERMINATED